143 related articles for article (PubMed ID: 36765645)
1. Risk Group Stratification for Recurrence-Free Survival and Early Tumor Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma.
Cha DI; Ahn SH; Lee MW; Jeong WK; Song KD; Kang TW; Rhim H
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765645
[TBL] [Abstract][Full Text] [Related]
2. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
[TBL] [Abstract][Full Text] [Related]
3. Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma.
Lee J; Jin YJ; Shin SK; Kwon JH; Kim SG; Suh YJ; Jeong Y; Yu JH; Lee JW; Kwon OS; Nahm SW; Kim YS
Clin Mol Hepatol; 2022 Apr; 28(2):207-218. PubMed ID: 34814239
[TBL] [Abstract][Full Text] [Related]
4. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
[TBL] [Abstract][Full Text] [Related]
5. Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study.
Xin Y; Zhang X; Yang Y; Chen Y; Wang Y; Zhou X; Li X
J Gastrointest Oncol; 2021 Dec; 12(6):2930-2942. PubMed ID: 35070419
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
[No Abstract] [Full Text] [Related]
7. Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
Zhuang BW; Li W; Wang W; Li B; Lu MD; Kuang M; Xie XH; Xie XY
Eur Radiol; 2021 Jul; 31(7):5379-5389. PubMed ID: 33404697
[TBL] [Abstract][Full Text] [Related]
8. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
[TBL] [Abstract][Full Text] [Related]
9. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
Front Oncol; 2022; 12():946531. PubMed ID: 35936698
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.
Xin Y; Yang Y; Liu N; Chen Y; Wang Y; Zhang X; Li X; Zhou X
J Gastrointest Oncol; 2021 Apr; 12(2):735-750. PubMed ID: 34012662
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia.
Liu YW; Yen YH; Li WF; Wang CC; Lu SN; Kee KM; Yong CC; Cheng YF; Wang JH; Hu TH; Hung CH; Chen CH
Surg Oncol; 2022 Jun; 42():101769. PubMed ID: 35468499
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma.
Hur MH; Lee JH; Kim JY; Hong JH; Park MK; Cho HJ; Choi NR; Kim J; Kim MA; Nam JY; Lee YB; Cho EJ; Yu SJ; Kim YJ; Lee DH; Lee JM; Hong SK; Yi NJ; Lee KW; Suh KS; Yoon JH
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885118
[TBL] [Abstract][Full Text] [Related]
13. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
14. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma.
Yoo J; Lee MW; Lee DH; Lee JH; Han JK
Liver Int; 2020 May; 40(5):1189-1200. PubMed ID: 32056353
[TBL] [Abstract][Full Text] [Related]
16. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
[TBL] [Abstract][Full Text] [Related]
17. A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Xin Y; Zhang X; Li Y; Yang Y; Chen Y; Wang Y; Zhou X; Li X
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):43-53. PubMed ID: 34561739
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of radiofrequency ablation for patients with BCLC B1 stage hepatocellular carcinoma downgraded by transarterial chemoembolization.
Li L; Xin Y; Zhang X; Chen Y; Yang Y; Zhou X; Ye F
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101878. PubMed ID: 35151909
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.
Shi F; Tan Z; An H; Wang X; Xu Y; Wang S
Ann Hepatol; 2016; 15(1):61-70. PubMed ID: 26626642
[TBL] [Abstract][Full Text] [Related]
20. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score Model.
Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
